Final results from M72 AS01E TB Vaccine Trial
The final results from the M72AS01E TB vaccine study have been published in the New England Journal of Medicine. The vaccine demonstrated a 50% efficacy rate in the incidence of lung TB disease in HIV-negative adults, already infected with latent...
Beat TB drama production
Beat TB, a Welcome Trust funded street theater production which raised awareness about tuberculosis (TB) and vaccine research understanding amongst the broader public of the Worcester area. during 2016.
2018 Tb under the Spotlight Science Engagement
The “TB Under the Spotlight Science Engagement” programme was conceptualised and presented by South African Tuberculosis Vaccine Initiative (SATVI) with scientists from the Division of Molecular Biology and Human Genetics at Stellenbosch University...
Biomarker discovery offers hope for new TB vaccine development
A team of scientists from the University of Cape Town, Oxford University and the London School of Hygiene & Tropical Medicine have made a discovery that reveals how we can improve development of more effective vaccines against tuberculosis.
Community Engagement
Carina's Choice: SATVI collaborated with UCT Drama Department and Worcester Secondary School in developing this play which was performed by learners from Worcester Secondary School at 8 local high schools reaching approximately 8 000 adolescents in...


Sunday, 7 June 2020
22 November 2019 Research Preferred product characteristics for therapeutive vaccines

Professor Mark Hatherill has co-authored a journal article titled: "Preferred product characteristics for therapeutic vaccines to improve tuberculosis treatment outcomes: Key considerations from World Health Organisation consultations" appearing in the Vaccine journal.

Publication Date:
Fri, 22 Nov 2019 - 13:45
14 November 2019 Research: Book Chapter: Diagnosing childhood tuberculosis during a vaccine trial in South Africa.

Dr Michèle Tameris, has co-authored a book chapter titled "Between representing and intervening: Diagnosing childhood tuberculosis during a vaccine trial in South Africa".

Publication Date:
Thu, 14 Nov 2019 - 22:45
SATVI researcher Dr Luabeya awarded ‘C’ rating from the South African National Research Foundation.

Dr Angelique Luabeya has been awarded "C" rating from the National Research Foundation.

Publication Date:
Wed, 13 Nov 2019 - 15:45
4 November 2019 SATVI Senior Research officer Elisa Nemes promoted to Associate Professor

The interim Dean of the UCT Faculty of Health Sciences has just announced that SATVI Senior Research Officer, Elisa Nemes has been promoted to Associate Professor. 

Publication Date:
Mon, 04 Nov 2019 - 15:30